Ring chromosome 22 and neurofibromatosis

Area of Science:

• Cytogenetics
• Human Genetics
• Oncology

Background:

• Neurofibromatosis encompasses a spectrum of genetic disorders.
• Chromosome 22 abnormalities, particularly involving the NF2 locus, are implicated in certain neurofibromatosis types.
• Understanding mosaicism is crucial for diagnosing complex genetic conditions.

Observation:

• Variable constitutional mosaicism (45,XY,-22/46,XY,-22,+mar/46,XY,-22,+r(22)/47,XY,-22,+r(22)+mar/47,XY,-22,+r(22)*2) was detected in multiple tissues of a patient with neurofibromatosis and intellectual disability.
• Ring chromosome 22 (r(22)) and a marker chromosome showed hybridization with a chromosome 14/22-specific probe.
• Arylsulfatase A (ARSA) gene deletion was identified, consistent with its 22q location.

Findings:

• No constitutional loss of D22S1 or D22S28, flanking the NF2 locus, was observed.
• Tumor analysis showed retention of D22S1 and ambiguous loss of D22S28.
• The study proposes that somatic mutation of the NF2 locus, driven by r(22) instability, may contribute to neurofibromatosis of unclear type.

Implications:

• Somatic mutations in NF1 or NF2 may explain neurofibromatosis cases not meeting standard criteria.
• The presence of a seminoma-associated locus on chromosome 22 is considered a possible explanation for the patient's seminoma.
• This research highlights the complex genetic mechanisms underlying neurofibromatosis and associated conditions.